{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:33:09Z","timestamp":1787877189774,"version":"build-2784847793"},"reference-count":122,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myeloproliferative neoplasms (MPNs) are a heterogeneous group of chronic hematological diseases that arise from the clonal expansion of abnormal hematopoietic stem cells, of which polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) have been extensively reviewed in the context of control of clonal expansion, fibrosis, and other phenotypes. Herein, we review current knowledge on the influence of different forms of MPN on bone health. In studies, murine models and human data have implicated various degrees of effect of different forms of MPN on bone density and on osteoblast proliferation and differentiation. Most results have shown that bone volume is generally increased in patients with PMF, whereas it is slightly decreased or not altered in patients with ET or PV, although possible differences between male and female phenotypes were not fully explored in most MPN forms. Osteosclerosis in patients with PMF is a serious complication that can lead to bone marrow failure, and the loss of bone reported in some patients with ET or PV can lead to osteoporotic fractures. Some MPN forms are associated with an increased number of megakaryocytes (MKs), and several of the MK-associated factors in MPN are known to affect bone development. We review known mechanisms involved in these processes, with a focus on the role of MKs and secreted factors. Understanding MPN-associated changes in bone health could improve early intervention and treatment of this side effect of the pathology.<\/jats:p>","DOI":"10.1182\/blood.2021011480","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T19:08:17Z","timestamp":1629832097000},"page":"3127-3137","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-4132","authenticated-orcid":false,"given":"Aikaterini","family":"Karagianni","sequence":"first","affiliation":[{"name":"1Department of Medicine and"},{"name":"2Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA; and"},{"name":"3Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Ravid","sequence":"additional","affiliation":[{"name":"1Department of Medicine and"},{"name":"2Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2022052615231583300_B1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"6","key":"2022052615231583300_B2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajh.23690","article-title":"How common are myeloproliferative neoplasms? A systematic review and meta-analysis","volume":"89","author":"Titmarsh","year":"2014","journal-title":"Am J Hematol."},{"issue":"4","key":"2022052615231583300_B3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.mayocp.2018.08.022","article-title":"3023 Mayo Clinic patients with myeloproliferative neoplasms:risk-stratified comparison of survival and outcomes data among disease subgroups","volume":"94","author":"Szuber","year":"2019","journal-title":"Mayo Clinic Proceed."},{"issue":"12","key":"2022052615231583300_B4","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia:2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am J Hematol."},{"issue":"9464","key":"2022052615231583300_B5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet."},{"issue":"1","key":"2022052615231583300_B6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.26050","article-title":"Primary myelofibrosis:2021 update on diagnosis, risk-stratification and management","volume":"96","author":"Tefferi","year":"2021","journal-title":"Am J Hematol."},{"issue":"5","key":"2022052615231583300_B7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med."},{"issue":"7","key":"2022052615231583300_B8","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med."},{"issue":"21","key":"2022052615231583300_B9","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1182\/blood-2013-02-486050","article-title":"Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms","volume":"121","author":"Rumi","year":"2013","journal-title":"Blood."},{"issue":"25","key":"2022052615231583300_B10","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med."},{"issue":"2","key":"2022052615231583300_B11","doi-asserted-by":"crossref","first-page":"a034876","DOI":"10.1101\/cshperspect.a034876","article-title":"The molecular genetics of myeloproliferative neoplasms","volume":"10","author":"Marneth","year":"2020","journal-title":"Cold Spring Harb Prospect Med."},{"issue":"3","key":"2022052615231583300_B12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bjh.14269","article-title":"Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera","volume":"175","author":"Delic","year":"2016","journal-title":"Br J Haematol."},{"issue":"15","key":"2022052615231583300_B13","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med."},{"key":"2022052615231583300_B14","article-title":"Phylogenetic reconstruction of myeloproliferative neoplasm reveals very early origins and lifelong evolution","author":"Williams","year":"2020","journal-title":"BioRxiv"},{"issue":"3","key":"2022052615231583300_B15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.stem.2021.02.001","article-title":"Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms","volume":"28","author":"Van Egeren","year":"2021","journal-title":"Cell Stem Cell."},{"key":"2022052615231583300_B16","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2013.2","article-title":"Differentiation of mesenchymal stem cells to osteoblasts and chondrocytes: a focus on adenosine receptors [online publication]","volume":"15","author":"Carroll","year":"2013","journal-title":"Expert Rev Mol Med."},{"issue":"2","key":"2022052615231583300_B17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4","article-title":"All for one and one for all: condensations and the initiation of skeletal development","volume":"22","author":"Hall","year":"2000","journal-title":"BioEssays."},{"issue":"50","key":"2022052615231583300_B18","doi-asserted-by":"crossref","first-page":"19004","DOI":"10.1073\/pnas.0605170103","article-title":"Dominance of SOX9 function over RUNX2 during skeletogenesis","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"2022052615231583300_B19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell."},{"issue":"1","key":"2022052615231583300_B20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell."},{"issue":"5","key":"2022052615231583300_B21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11914-019-00524-y","article-title":"Cellular processes by which osteoblasts and osteocytes control bone mineral deposition and maturation revealed by stage-specific EphrinB2 knockdown","volume":"17","author":"Blank","year":"2019","journal-title":"Curr Osteoporos Rep."},{"issue":"4","key":"2022052615231583300_B22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jb\/mvv124","article-title":"Regulation of bone metabolism by Wnt signals","volume":"159","author":"Kobayashi","year":"2016","journal-title":"J Biochem."},{"issue":"08 8A","key":"2022052615231583300_B23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4236\/jbise.2013.68A1004","article-title":"BMP signaling in mesenchymal stem cell differentiation and bone formation","volume":"6","author":"Beederman","year":"2013","journal-title":"J Biomed Sci Eng."},{"key":"2022052615231583300_B24","doi-asserted-by":"crossref","first-page":"729352","DOI":"10.1155\/2015\/729352","article-title":"Functional diversity of fibroblast growth factors in bone formation","volume":"2015","author":"Takei","year":"2015","journal-title":"Int J Endocrinol."},{"issue":"1","key":"2022052615231583300_B25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.11613\/BM.2013.007","article-title":"Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts","volume":"23","author":"Zupan","year":"2013","journal-title":"Biochemia Med."},{"issue":"11","key":"2022052615231583300_B26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol Metab."},{"key":"2022052615231583300_B27","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2215\/CJN.05910809","article-title":"Calcium metabolism in health and disease","volume":"5","author":"Peacock","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"2022052615231583300_B28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3324\/haematol.2013.096859","article-title":"The importance of calcium in the regulation of megakaryocyte function","volume":"99","author":"Di Buduo","year":"2014","journal-title":"Haematologica."},{"issue":"2","key":"2022052615231583300_B29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood.2019001103","article-title":"Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms","volume":"135","author":"Di Buduo","year":"2020","journal-title":"Blood.."},{"issue":"1","key":"2022052615231583300_B30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2405043","article-title":"Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F","volume":"22","author":"Shide","year":"2008","journal-title":"Leukemia."},{"issue":"4","key":"2022052615231583300_B31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/JBMR.0301254","article-title":"Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2","volume":"19","author":"Kacena","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2022052615231583300_B32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bone.2004.09.024","article-title":"Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype","volume":"36","author":"Kacena","year":"2005","journal-title":"Bone."},{"issue":"17","key":"2022052615231583300_B33","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-439661","article-title":"Characterization of the TGF-\u03b21 signaling abnormalities in the Gata1low mouse model of myelofibrosis","volume":"121","author":"Zingariello","year":"2013","journal-title":"Blood."},{"issue":"11","key":"2022052615231583300_B34","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1182\/blood.V90.11.4369","article-title":"High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice","volume":"90","author":"Villeval","year":"1997","journal-title":"Blood."},{"key":"2022052615231583300_B35","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1182\/blood-2019-124186","article-title":"Megakaryocyte-driven myelofibrosis leads to progressive osteosclerosis in G6b-B knockout mice","volume":"134","author":"Stavnichuk","year":"2019","journal-title":"Blood."},{"issue":"4","key":"2022052615231583300_B36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.4245","article-title":"Severity of megakaryocyte-driven osteosclerosis in Mpig6b-deficient mice is sex-linked","volume":"36","author":"Stavnichuk","year":"2021","journal-title":"J Bone Miner Res."},{"issue":"13","key":"2022052615231583300_B37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood-2017-08-802769","article-title":"Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice","volume":"132","author":"Hofmann","year":"2018","journal-title":"Blood."},{"issue":"3","key":"2022052615231583300_B38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jcp.35.3.257","article-title":"Bone biopsy in haematological disorders","volume":"35","author":"Burkhardt","year":"1982","journal-title":"J Clin Pathol."},{"issue":"3","key":"2022052615231583300_B39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/path.1711440303","article-title":"Histomorphometric analysis of sclerotic bone from idiopathic myeloid metaplasia (nine cases)","volume":"144","author":"Coindre","year":"1984","journal-title":"J Pathol."},{"issue":"6","key":"2022052615231583300_B40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0344-0338(89)80164-5","article-title":"Osteoclasts and bone remodeling in chronic myeloproliferative disorders. A histochemical and morphometric study on trephine biopsies in 165 patients","volume":"184","author":"Thiele","year":"1989","journal-title":"Pathol Res Pract."},{"issue":"4","key":"2022052615231583300_B41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1699-0463.1998.tb01377.x","article-title":"A histomorphometric study of haematological disorders with respect to marrow fibrosis and osteosclerosis","volume":"106","author":"Poulsen","year":"1998","journal-title":"APMIS."},{"issue":"3","key":"2022052615231583300_B42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S8756-3282(01)00695-0","article-title":"Syndrome of myelofibrosis and osteosclerosis:a series of case reports and review of the literature","volume":"30","author":"Diamond","year":"2002","journal-title":"Bone."},{"issue":"2","key":"2022052615231583300_B43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bone.2003.10.010","article-title":"Relationship among densitometry, bone histomorphometry, and histologic stage in idiopathic myelofibrosis","volume":"34","author":"Mellibovsky","year":"2004","journal-title":"Bone."},{"issue":"6","key":"2022052615231583300_B44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-0609.2007.00852.x","article-title":"Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study","volume":"78","author":"Schmidt","year":"2007","journal-title":"Eur J Haematol."},{"issue":"7","key":"2022052615231583300_B45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.leukres.2010.01.005","article-title":"Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study","volume":"34","author":"Teman","year":"2010","journal-title":"Leukemia Res."},{"issue":"1","key":"2022052615231583300_B46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12185-015-1803-3","article-title":"Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers [published correction appears in Int J Hemtol. 102:388]","volume":"102","author":"Farmer","year":"2015","journal-title":"Int J Hematol."},{"issue":"5","key":"2022052615231583300_B47","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood."},{"issue":"4","key":"2022052615231583300_B48","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00198-015-3412-7","article-title":"Polycythemia is associated with bone loss and reduced osteoblast activity in mice","volume":"27","author":"Oikonomidou","year":"2016","journal-title":"Osteoporosis Int."},{"issue":"4","key":"2022052615231583300_B49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jbmr.3026","article-title":"Bone health in patients with hematopoietic disorders of bone marrow origin: systematic review and meta-analysis","volume":"32","author":"Steer","year":"2017","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2022052615231583300_B50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/bjh.12581","article-title":"Chronic myeloproliferative neoplasms and risk of osteoporotic fractures: a nationwide population-based cohort study","volume":"163","author":"Farmer","year":"2013","journal-title":"Br J Haematol."},{"issue":"2","key":"2022052615231583300_B51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S0004-27302010000200002","article-title":"Bone histomorphometry: a concise review for endocrinologists and clinicians","volume":"54","author":"Kulak","year":"2010","journal-title":"Arq Bras Endocrinol Metab."},{"key":"2022052615231583300_B52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40842-018-0062-7","article-title":"The challenges of diagnosing osteoporosis and the limitations of currently available tools","volume":"4","author":"Choksi","year":"2018","journal-title":"Clin Diabetes Endocrinol."},{"issue":"1","key":"2022052615231583300_B53","doi-asserted-by":"crossref","first-page":"100005","DOI":"10.1016\/j.cytox.2019.100005","article-title":"Cytokines frequently implicated in myeloproliferative neoplasms","volume":"1","author":"Wang","year":"2019","journal-title":"Cytokine X."},{"issue":"4","key":"2022052615231583300_B54","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s12032-011-0144-1","article-title":"The relationship of the active and latent forms of TGF-\u03b21 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis","volume":"29","author":"Ponce","year":"2012","journal-title":"Med Oncol."},{"issue":"62","key":"2022052615231583300_B55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.01.007","article-title":"Transforming growth factor \u03b2- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow","volume":"62","author":"Nakayama","year":"2017","journal-title":"Hum Pathol."},{"issue":"2","key":"2022052615231583300_B56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.htct.2017.12.003","article-title":"Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [published correction appears in Hematol Transfus Cell Ther. 2021;43(1):117]","volume":"40","author":"Cacemiro","year":"2018","journal-title":"Hematol Transfus Cell Ther."},{"issue":"10","key":"2022052615231583300_B57","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis:a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol."},{"issue":"11","key":"2022052615231583300_B58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera:phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am J Hematol."},{"issue":"7","key":"2022052615231583300_B59","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1182\/blood.V74.7.2330.2330","article-title":"Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders","volume":"74","author":"Gersuk","year":"1989","journal-title":"Blood."},{"issue":"1","key":"2022052615231583300_B60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.1991.tb07952.x","article-title":"Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia","volume":"77","author":"Martyr\u00e9","year":"1991","journal-title":"Br J Haematol."},{"issue":"5","key":"2022052615231583300_B61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2014.01.006","article-title":"Cytokine profiles in polycythemia vera and essential thrombocythemia patients:clinical implications","volume":"42","author":"Pourcelot","year":"2014","journal-title":"Exp Hematol."},{"issue":"2","key":"2022052615231583300_B62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood-2003-12-4415","article-title":"IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis","volume":"105","author":"Emadi","year":"2005","journal-title":"Blood."},{"issue":"6","key":"2022052615231583300_B63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10245330701554664","article-title":"Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases","volume":"12","author":"Panteli","year":"2007","journal-title":"Hematology."},{"issue":"3","key":"2022052615231583300_B64","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00277-016-2890-9","article-title":"Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms:clinicopathological and molecular correlations","volume":"96","author":"Lekovic","year":"2017","journal-title":"Ann Hematol."},{"issue":"5","key":"2022052615231583300_B65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ajh.23409","article-title":"The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms","volume":"88","author":"Tadmor","year":"2013","journal-title":"Am J Hematol."},{"issue":"6","key":"2022052615231583300_B66","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2017-04-777417","article-title":"Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis","volume":"130","author":"Abbonante","year":"2017","journal-title":"Blood."},{"issue":"18","key":"2022052615231583300_B67","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.2019004095","article-title":"Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN","volume":"136","author":"Gleitz","year":"2020","journal-title":"Blood."},{"issue":"8","key":"2022052615231583300_B68","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1359\/jbmr.2000.15.8.1459","article-title":"Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation","volume":"15","author":"Quinn","year":"2000","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2022052615231583300_B69","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J Clin Invest."},{"issue":"1","key":"2022052615231583300_B70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.1998.4320","article-title":"Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells","volume":"247","author":"Jimi","year":"1999","journal-title":"Exp Cell Res."},{"issue":"1","key":"2022052615231583300_B71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2119\/molmed.2012.00058","article-title":"IL-1\u03b2 inhibits human osteoblast migration","volume":"19","author":"Hengartner","year":"2013","journal-title":"Mol Med."},{"issue":"23","key":"2022052615231583300_B72","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"2022052615231583300_B73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone."},{"issue":"6","key":"2022052615231583300_B74","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12185-019-02751-6","article-title":"Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice","volume":"110","author":"Leiva","year":"2019","journal-title":"Int J Hematol."},{"issue":"5","key":"2022052615231583300_B75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00223-008-9136-3","article-title":"Collagen cross-linking influences osteoblastic differentiation","volume":"82","author":"Turecek","year":"2008","journal-title":"Calcif Tissue Int."},{"issue":"6","key":"2022052615231583300_B76","doi-asserted-by":"crossref","first-page":"e100669","DOI":"10.1371\/journal.pone.0100669","article-title":"A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia","volume":"9","author":"Khosravi","year":"2014","journal-title":"PloS One."},{"issue":"6","key":"2022052615231583300_B77","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3892\/ijmm.2015.2384","article-title":"Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells","volume":"36","author":"Sharma-Bhandari","year":"2015","journal-title":"Int J Mol Med."},{"issue":"2","key":"2022052615231583300_B78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00223-009-9252-8","article-title":"Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype","volume":"85","author":"Pischon","year":"2009","journal-title":"Calcif Tissue Int."},{"issue":"29","key":"2022052615231583300_B79","doi-asserted-by":"crossref","first-page":"30060","DOI":"10.1074\/jbc.M404208200","article-title":"Regulation of collagen deposition and lysyl oxidase by tumor necrosis factor-alpha in osteoblasts","volume":"279","author":"Pischon","year":"2004","journal-title":"J Biol Chem."},{"issue":"6","key":"2022052615231583300_B80","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bone.2011.08.027","article-title":"Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral","volume":"49","author":"Paschalis","year":"2011","journal-title":"Bone."},{"issue":"3","key":"2022052615231583300_B81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbmr.2356","article-title":"Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model","volume":"30","author":"McNerny","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2022052615231583300_B82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ydbio.2009.06.002","article-title":"Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development","volume":"332","author":"Matsunobu","year":"2009","journal-title":"Dev Biol."},{"issue":"5","key":"2022052615231583300_B83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2362.2000.00645.x","article-title":"Production and action of transforming growth factor-beta in human osteoblast cultures:dependence on cell differentiation and modulation by calcitriol","volume":"30","author":"Kassem","year":"2000","journal-title":"Eur J Clin Invest."},{"issue":"1","key":"2022052615231583300_B84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","article-title":"Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation","volume":"200","author":"Karst","year":"2004","journal-title":"J Cell Physiol."},{"issue":"11","key":"2022052615231583300_B85","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1517\/13543780903241607","article-title":"Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing","volume":"18","author":"Graham","year":"2009","journal-title":"Expert Opin Investig Drugs."},{"issue":"2","key":"2022052615231583300_B86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jcp.1041640217","article-title":"Effect of platelet-derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats","volume":"164","author":"Tanaka","year":"1995","journal-title":"J Cell Physiol."},{"issue":"3","key":"2022052615231583300_B87","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0006-291X(91)91629-Q","article-title":"Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1)","volume":"175","author":"Tsukamoto","year":"1991","journal-title":"Biochem Biophys Res Commun."},{"issue":"7","key":"2022052615231583300_B88","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/jbmr.5650110911","article-title":"Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro","volume":"11","author":"Cassiede","year":"1996","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2022052615231583300_B89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09537100310001643999","article-title":"Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions","volume":"15","author":"Gruber","year":"2004","journal-title":"Platelets."},{"key":"2022052615231583300_B90","doi-asserted-by":"crossref","first-page":"3272098","DOI":"10.1155\/2018\/3272098","article-title":"The effects of platelet-derived growth factor-BB on bone marrow stromal cell-mediated vascularized bone regeneration","volume":"2018","author":"Zhang","year":"2018","journal-title":"Stem Cells Int."},{"issue":"4","key":"2022052615231583300_B91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-016-0773-8","article-title":"Platelet-derived growth factor BB enhances osteoclast formation and osteoclast precursor cell chemotaxis","volume":"35","author":"Li","year":"2017","journal-title":"J Bone Miner Metab."},{"issue":"12","key":"2022052615231583300_B92","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest."},{"issue":"2","key":"2022052615231583300_B93","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1190","article-title":"Proinflammatory cytokine (TNFalpha\/IL-1alpha) induction of human osteoclast formation","volume":"198","author":"Kudo","year":"2002","journal-title":"J Pathol."},{"issue":"2","key":"2022052615231583300_B94","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bone.2009.04.252","article-title":"TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway","volume":"45","author":"Hess","year":"2009","journal-title":"Bone."},{"issue":"8","key":"2022052615231583300_B95","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/dvdy.23992","article-title":"Angiogenesis and intramembranous osteogenesis","volume":"242","author":"Percival","year":"2013","journal-title":"Dev Dyn."},{"issue":"Pt 1","key":"2022052615231583300_B96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1242\/jcs.113.1.59","article-title":"Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation","volume":"113","author":"Carlevaro","year":"2000","journal-title":"J Cell Sci."},{"issue":"4","key":"2022052615231583300_B97","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jcb.20462","article-title":"Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells:autocrine and paracrine role on osteoblastic and endothelial differentiation","volume":"95","author":"Mayer","year":"2005","journal-title":"J Cell Biochem."},{"issue":"9","key":"2022052615231583300_B98","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1172\/JCI61209","article-title":"Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation","volume":"122","author":"Liu","year":"2012","journal-title":"J Clin Invest."},{"issue":"7","key":"2022052615231583300_B99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.matbio.2008.06.005","article-title":"VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin","volume":"27","author":"Yang","year":"2008","journal-title":"Matrix Biol."},{"issue":"6","key":"2022052615231583300_B100","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J Immunol."},{"issue":"2","key":"2022052615231583300_B101","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J Clin Invest."},{"issue":"17","key":"2022052615231583300_B102","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J Biol Chem."},{"issue":"8","key":"2022052615231583300_B103","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00018-014-1813-y","article-title":"The secret life of a megakaryocyte:emerging roles in bone marrow homeostasis control","volume":"72","author":"Malara","year":"2015","journal-title":"Cell Mol Life Sci."},{"issue":"26","key":"2022052615231583300_B104","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1182\/blood-2012-10-463414","article-title":"Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning","volume":"121","author":"Olson","year":"2013","journal-title":"Blood."},{"issue":"1","key":"2022052615231583300_B105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2559.1990.tb00665.x","article-title":"Megakaryocytes in myelodysplasia: an immunohistochemical study on bone marrow trephines","volume":"17","author":"Fox","year":"1990","journal-title":"Histopathology."},{"issue":"4","key":"2022052615231583300_B106","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jcp.44.4.300","article-title":"Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.","volume":"44","author":"Thiele","year":"1991","journal-title":"J Clin Pathol."},{"issue":"2","key":"2022052615231583300_B107","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/2278-330X.208854","article-title":"Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm","volume":"6","author":"Ghai","year":"2017","journal-title":"South Asian J Cancer."},{"issue":"66","key":"2022052615231583300_B108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2014.05.015","article-title":"Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiation","volume":"66","author":"Soves","year":"2014","journal-title":"Bone."},{"issue":"5","key":"2022052615231583300_B109","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bone.2006.05.004","article-title":"Megakaryocyte-mediated inhibition of osteoclast development","volume":"39","author":"Kacena","year":"2006","journal-title":"Bone."},{"issue":"5","key":"2022052615231583300_B110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bone.2004.12.006","article-title":"Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL","volume":"36","author":"Bord","year":"2005","journal-title":"Bone."},{"issue":"5","key":"2022052615231583300_B111","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bone.2006.06.004","article-title":"Osteoclast formation and bone resorption are inhibited by megakaryocytes","volume":"39","author":"Beeton","year":"2006","journal-title":"Bone."},{"issue":"1","key":"2022052615231583300_B112","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2008.08.117","article-title":"The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation","volume":"44","author":"Ciovacco","year":"2009","journal-title":"Bone."},{"issue":"5","key":"2022052615231583300_B113","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jcb.22468","article-title":"Involvement of integrins alpha(3)beta(1) and alpha(5)beta(1) and glycoprotein IIb in megakaryocyte-induced osteoblast proliferation","volume":"109","author":"Lemieux","year":"2010","journal-title":"J Cell Biochem."},{"issue":"21","key":"2022052615231583300_B114","doi-asserted-by":"crossref","first-page":"17257","DOI":"10.1074\/jbc.M111.309880","article-title":"Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts","volume":"287","author":"Kacena","year":"2012","journal-title":"J Biol Chem."},{"issue":"3","key":"2022052615231583300_B115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jcp.24774","article-title":"Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells","volume":"230","author":"Cheng","year":"2015","journal-title":"J Cell Physiol."},{"issue":"127","key":"2022052615231583300_B116","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bone.2019.07.010","article-title":"Aging negatively impacts the ability of megakaryocytes to stimulate osteoblast proliferation and bone mass","volume":"127","author":"Maupin","year":"2019","journal-title":"Bone."},{"issue":"4","key":"2022052615231583300_B117","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jcb.22456","article-title":"Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation","volume":"109","author":"Ciovacco","year":"2010","journal-title":"J Cell Biochem."},{"issue":"5","key":"2022052615231583300_B118","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2007-07-104281","article-title":"Long-term imatinib therapy promotes bone formation in CML patients","volume":"111","author":"Fitter","year":"2008","journal-title":"Blood."},{"issue":"4","key":"2022052615231583300_B119","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5694\/j.1326-5377.2000.tb125597.x","article-title":"Predictors of bone mass in healthy older men in the community","volume":"173","author":"Smerdely","year":"2000","journal-title":"Med J Aust."},{"issue":"7","key":"2022052615231583300_B120","first-page":"469","article-title":"Donn\u00e8es histologiques quantitatives sur le vieillissement osseux humain [Quantitative histological data on the aging of human bone]","volume":"40","author":"Courpron","year":"1973","journal-title":"Rev Rhum Mal Osteoartic."},{"key":"2022052615231583300_B121","first-page":"100","volume-title":"Proceedings of the First Workshop on Bone Morphometry.","author":"Meunier","year":"1973"},{"issue":"1","key":"2022052615231583300_B122","first-page":"70","article-title":"Histomorphometric analysis of normal bone from the iliac crest.","volume":"86","author":"Melsen","year":"1978","journal-title":"Acta Pathol Microbiol Scand A."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/21\/3127\/1898557\/bloodbld2021011480c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/21\/3127\/1898557\/bloodbld2021011480c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T20:33:34Z","timestamp":1699389214000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/21\/3127\/476662\/Myeloproliferative-disorders-and-their-effects-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":122,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021011480","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}